Agglutination immunoassays carried out with agent to reduce non-

Chemistry: physical processes – Physical processes – Crystallization

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

23915, 252408, 424 1, 424 12, G01N 3354, G01N 3378

Patent

active

043625312

ABSTRACT:
In particle agglutination immunoassays for an analyte (e.g. an antigen or antibody) in a liquid sample (e.g. human serum), interferences arise due to non-specific protein-protein interactions and the like. These interferences are reduced or overcome by including in the assay mixture a chaotropic or chaotropic-like agent, in a carefully controlled amount. Such agents include guanidine, guanidinium hydrochloride or thiocyanate, sodium or ammonium thiocyanate, and urea, sodium chloride and ethylenediamine tetraacetic acid.

REFERENCES:
patent: 3791932 (1974-02-01), Schuurs
patent: 4200436 (1980-04-01), Mochido
patent: 4292038 (1981-09-01), Kondo
patent: 4298593 (1981-11-01), Ling
patent: 4299815 (1981-11-01), Hansen
patent: 4305925 (1981-12-01), Kapmeyer
H. L. Vader et al., Clinica Chimica Acta, 80, 361-372, (1977).
Chemical Abstracts, 90:20740c, (1979).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agglutination immunoassays carried out with agent to reduce non- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agglutination immunoassays carried out with agent to reduce non-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agglutination immunoassays carried out with agent to reduce non- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1901238

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.